Q. Xie

Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma

Xiaoping Zhou, Lingjuan Zhu, Wenke Jin, 2021, Pharmacogenetics and genomics.

Safety, tolerability, pharmacodynamics, and pharmacokinetics of CJC-1134-PC in healthy Chinese subjects and type-2 diabetic subjects

Hong Zhang, Yanhua Ding, Xiping Liu, 2021, Expert opinion on investigational drugs.

Phosphorylation of Mutationally Introduced Tyrosine in the Activation Loop of HER2 Confers Gain-of-Function Activity

Yibo Gao, She Chen, Lin Li, 2015, PloS one.

Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

R. Xi, Deruo Liu, Q. Xie, 2015, Oncotarget.

Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration

J. Yu, Y. Yang, F. Zhao, 2014, Oncogene.

Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study.

Q. Liu, Caicun Zhou, Yun Fan, 2023, European journal of cancer.

Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

R. Xi, Deruo Liu, Q. Xie, 2015, Oncotarget.

De novo lipogenesis prolongs the lifespan and supports the immunosuppressive phenotype of neutrophils in HCC metastasis

Eric Chang, Q. Xie, Chaojie Hu, 2022, Genes & diseases.